4DMedical stock heads into its October 28 AGM

Published on 10/07/2026 at 05:33 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

4DMedical stock was last at AUD 4.07 on October 6, 2026, below its AUD 7.55 52-week high. Fiscal 2026 revenue rose 20.7 percent to AUD 7.06 million.

4Dmedical, AU0000095416, Illustration mit AI erstellt.

4DMedical stock (ISIN AU0000095416) was last at AUD 4.07 on the ASX on October 6, 2026, leaving the share price 46.09 percent below its 52-week high of AUD 7.55. The next dated checkpoint is the company's annual general meeting on October 28, 2026, according to 4DMedical.

October 28 meeting sets the next checkpoint

The AGM will be held at 10:00 a.m. AEDT on October 28, 2026. The investor-services page identifies 4DX as the company's ASX code and places the meeting in Melbourne, giving shareholders a defined date for decisions on governance and leadership.

The meeting follows a proposed board reset that includes Julian Sutton moving into the executive chair role after the AGM and Professor Christine Jenkins joining as an independent non-executive director. The governance changes matter because 4DMedical is moving from technology development toward wider commercial deployment of its respiratory imaging products.

Revenue growth meets a large statutory loss

For the fiscal year ended June 30, 2026, revenue rose 20.7 percent to AUD 7.06 million from AUD 5.85 million, while the reported net loss was AUD 204.43 million versus AUD 30.07 million a year earlier, according to RTTNews on September 24, 2026. The contrast leaves revenue conversion and cash use as the central financial questions ahead of the AGM.

4DMedical develops non-invasive respiratory imaging technology using its XV Technology and Imbio platforms, according to the company's investor page. That product focus gives the revenue increase a commercial dimension, but the statutory loss shows that scale has not yet translated into bottom-line profitability.

Share price remains below its yearly high

At AUD 4.07 on October 6, 2026, the stock stood AUD 3.48 below its 52-week high and AUD 2.67 above its 52-week low of AUD 1.40. The ASX-listed company had a market capitalization of AUD 2.5 billion and recorded volume of 3.01 million shares on the same dated quote.

For investors, the October 28 AGM combines a concrete governance date with a wide operating gap between revenue growth and statutory earnings. The stock's position within its AUD 1.40 to AUD 7.55 yearly range makes the fiscal 2026 figures especially relevant to how the market assesses commercial execution.

4DMedical stock stays below its yearly high

4DMedical stock was last at AUD 4.07 on the ASX on October 6, 2026. The quoted 52-week range was AUD 1.40-AUD 7.55, while market capitalization stood at AUD 2.5 billion.